Augment Health

Executive Summary

Augment Health is a San Francisco-based digital health and medical device company focused on developing smart bladder monitoring technology for patients with neurological conditions. Founded in 2019, the company addresses a significant unmet need in urological care for individuals with conditions such as spinal cord injury, multiple sclerosis, and Parkinson's disease, where bladder dysfunction is common and often leads to infections, kidney damage, and reduced quality of life. Augment's non-invasive, wearable sensor system aims to provide continuous monitoring of bladder volume, enabling timely intervention and data-driven management. The company operates in the intersection of neuro-urology and digital health, a growing market driven by aging populations and increased prevalence of neurological disorders. While financial details and stage are not publicly disclosed, the company's presence in the competitive San Francisco health-tech ecosystem and its specific focus on a chronic, underserved condition position it for potential partnerships with healthcare providers or medical device distributors. The product's success will depend on clinical validation and regulatory clearance.

Upcoming Catalysts (preview)

• Q2 2027FDA 510(k) Clearance or CE Mark for Bladder Monitoring Device55% success
• Q4 2026Publication of Pilot Clinical Study Results Demonstrating Accuracy and Usability70% success
• Q3 2026Strategic Partnership with a Major Neurology or Urology Clinic Network40% success